Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Much like how location can directly affect the price of a home, targeting specific areas of the brain can have an effect on the success of certain brain treatments. However, delivering treatment to the exact location in the brain that will provide the most benefit remains a daunting challenge.
To help address this challenge, researchers at Krembil Research Institute explored an emerging technique, known as magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy, for the treatment of essential tremor – a debilitating brain disorder that causes uncontrollable shaking. This study was done in collaboration with Sunnybrook Health Sciences Centre.
The approach uses high-resolution MR imaging to precisely target a tiny area of the brain called the thalamus. This brain region is responsible for relaying important motor and sensory signals in the brain and is a key target for essential tremor therapies.
By examining patients who underwent MRgFUS thalamotomy, the study found that clinical outcomes were largely dependent on the specific regions that were targeted within the thalamus. Just as in the real estate market, location seems to play a critical role in the clinical outcomes of these patients.
The researchers further mapped out areas that were associated with the best treatment responses, as well as those linked with an increased risk of detrimental side effects.
Using standard assessment methods, the research team found that use of MRgFUS led to an approximately 42 per cent improvement in tremor scores three months after treatment. The study also suggested that when smaller areas of the brain were targeted, side effects were less severe.
"These findings are a significant step toward improving the effectiveness of MRgFUS thalamotomy and will enable us to refine areas to target therapy so that we can improve outcomes and reduce adverse effects for patients," says
Dr. Andres M. Lozano, a neurosurgeon at Toronto Western Hospital and Krembil Senior Scientist.
This work was supported by Insightec and the Toronto General & Western Hospital Foundation. Dr. Lozano holds a Tier 1 Canada Research Chair in Neuroscience.
Read more about the study